Table 2.
Demographics and baseline characteristics
| Solid tumors (N=56) | Lymphomas (N=11) | |
| Median age, years (range) | 61 (26–81) | 62 (49–86) |
| Sex, male/female (%) | 28/28 (50/50) | 6/5 (55/45) |
| Race, n (%) | ||
| White | 44 (79) | 9 (82) |
| African American | 5 (9) | 0 |
| Asian | 2 (4) | 0 |
| American Indian or Alaska Native | 1 (2) | 0 |
| Other | 3 (5) | 0 |
| Unknown | 1 (2) | 2 (18) |
| Baseline ECOG status*, n (%) | ||
| 0 | 17 (30) | 3 (27) |
| 1 | 39 (70) | 8 (73) |
| Prior systemic therapies, n (%) | ||
| 1 | 6 (11) | 0 |
| 2 | 10 (18) | 2 (18) |
| 3 | 11 (20) | 0 |
| ≥4 | 29 (52) | 9 (82) |
| Types of solid tumors, n (%) | ||
| Head and neck squamous cell carcinoma | 7 (13) | — |
| Bladder carcinoma | 5 (9) | — |
| Breast carcinoma | 5 (9) | — |
| Renal cell carcinoma | 5 (9) | — |
| Esophageal carcinoma | 4 (7) | — |
| Melanoma | 4 (7) | — |
| Non-small cell lung carcinoma | 3 (5) | — |
| Pancreatic carcinoma | 3 (5) | — |
| Cholangiocarcinoma | 2 (4) | — |
| Gastric carcinoma | 2 (4) | — |
| Prostate carcinoma | 2 (4) | — |
| Other† | 14 (25) | — |
| Types of lymphomas, n (%) | ||
| DLBCL | — | 6 (55) |
| Hodgkin lymphoma‡ | — | 3 (27) |
| Follicular lymphoma | — | 2 (18) |
*Values for ECOG performance status range from 0 to 5, with higher scores indicating greater disability.
†Other includes anal squamous cell carcinoma, basal cell carcinoma, colon carcinoma, endometrial, gallbladder, gastroesophageal junction adenocarcinoma, gastroesophageal junction adenocarcinoma (gastric area), lacrimal adenoid cystic carcinoma, mesothelioma, ovarian carcinoma, rhabdomyosarcoma of the head and neck, soft tissue sarcoma, squamous cell cervical carcinoma, thyroid cancer.
‡Hodgkin lymphoma subtypes included mixed cellularity classical Hodgkin lymphoma (cHL) and nodular sclerosis cHL.
DLBCL, diffuse large B-cell lymphoma; ECOG, Eastern Cooperative Oncology Group.